Hocine Said is the founder of KELIX bio. KELIX bio has raised $200M in total funding. Latest round: Series B. Based in Malta.
Hocine Said is the Co-founder and CEO of KELIX bio, an emerging market biopharmaceutical platform established in November 2020. KELIX bio develops and commercializes affordable specialty medications to underserved populations across Africa and other emerging markets. The company has raised funds from various investors, including DPI, BII, EBRD, Proparco, DEG, FMO, and US private sector institutional investors.
Full founder directory · Investor directory · Company funding database · Fundraising library